Navigation Links
New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
Date:4/30/2013

for the brand name at the CVS Pharmacy. (7) The cost of the generic brand is only slightly less. In contrast, a month’s supply of Gene-Eden-VIR is $37.99. That’s over a thousand dollars less than the cost of Valtrex.

To learn more about Gene-Eden-VIR, visit http://www.gene-eden-kill-virus.com.

References:

(1)    http://www.ncbi.nlm.nih.gov/pubmed/23528373
(2)    http://jac.oxfordjournals.org/content/57/5/945.long
(3)    http://www.drugs.com/valacyclovir.html
(4)    http://www.drugs.com/sfx/valacyclovir-side-effects.html
(5)    http://www.cbcd.net/Gene-Eden-VIR-Clinical-Study.php
(6)    http://www.gene-eden-kill-virus.com/studies.php
(7)    http://herpesnews.com/herpes-medications/price-comparison-between-valtrex-generic-valtrex-and-acyclovir-in-united-states/

###

polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.

In additi
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Study: Brain Imaging After Mild Head Injury/Concussion Can Show Lesions
2. RPCI-Led Study: FAK Inhibitor Proves Effective Against Brain Tumors in Preclinical Studies
3. Nature Materials study: Boosting heat transfer with nanoglue
4. New Study: Health Professionals Support Biotechnologys Use In Food Products And Sustainable Farming
5. Nature Materials study: Graphene invisible to water
6. Breaking Study: ICU Medicals Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
7. Drink to Your (Oral) Health: Atlanta Dentist Looks at Two Recent Studies Exploring Green Tea’s Effects on Oral Health
8. Probiotic Action Explains New Research that Probiotics Help Reduce Stress Side Effects
9. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
10. ?The MedZilla.com Employment Report for January, 2013: Wrapping Up the Year in Employment Statistics: Recovery Efforts and the Coming Effects
11. University of Miami study finds RBAC to possess promising immunomodulating effects with respect to natural killer cell and cytokine activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... May 21, 2015 Veolia’s environmental ... exclusive North American distribution agreement with VWR to ... , With more than 160 years of experience, ... services for laboratory and production facilities, has cultivated ... and differentiated services to enable science. Endetec’s ...
(Date:5/20/2015)... (PRWEB) May 20, 2015 This year ... especially for lawns. US Patented Pearl’s Premium Ultra ... lawns around the country that are coming out of ... addresses a number of major global concerns related to ... “non-grass” grass – the alternative to the standard, water-wasting, ...
(Date:5/20/2015)... , May 20, 2015  Health eCareers, ... short-staffed healthcare organizations with job seekers looking for ... , a new mobile and online tool dedicated ... healthcare industry. SHIFT enables employers to ... tenens, travel nursing, per diem and other temporary ...
Breaking Biology Technology:CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 2Health eCareers Launches SHIFT Mobile and Online Tool to Match Healthcare Employers with Temporary Job Seekers 3
... NEW ORLEANS and PITTSBURGH, Oct. 22 A new,analysis ... and,African Americans are more likely than whites to use ... at the 2007 Annual,Scientific Meeting of NAASO, The Obesity ... awareness about recommended weight loss treatments,and the associated health ...
... Rene Bruno Will Present on the Value of ... Predict Efficacy and Survival Benefit of ... Pharsight,Corporation (OTC Bulletin Board: PHST), a leading ... optimizing clinical drug,development, today announced that Rene Bruno, ...
... WASHINGTON, Oct. 21 Boston,Scientific Corporation (NYSE: ... nearly 7,000 patients from its TAXUS ARRIVE 1 ... the TAXUS(R) Express2(TM) Paclitaxel-Eluting,Coronary Stent System in "real-world" ... of adverse events and repeat,revascularization through two years ...
Cached Biology Technology:New Data Reveal Ethnicity May Play Role in Weight Loss Decisions 2New Data Reveal Ethnicity May Play Role in Weight Loss Decisions 3Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China 2ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 2ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 3ARRIVE Registry Analysis Demonstrates Continued Safety and Efficacy of TAXUS(R) Stent in Complex Real-World Patients 4
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/7/2015)... May 7, 2015 Fingerprint ... FPC1022 and FPC1035, FPC,s smallest touch fingerprint sensors ... mainly considered for integration on the backside of ... OEMs increased possibilities to integrate touch fingerprint sensors ... also improves possibilities for module manufacturers to customize ...
(Date:4/27/2015)... , April 27, 2015  For more than four ... show has been the premier worldwide event for the ... is a must-attend event for any local, national, or ... the emerging commercial markets and current applications of unmanned ... of this projected $48 billion industry, and how it ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... emotions can be caused by a specific event and ... cause, such as a childs excitement at the sound ... emotions also can be unconsciously evoked and manipulated. ... Institute for Behavioral Economics Research at Tillburg University in ...
... of society,s most pressing problems the search for ... out the biomarkers of diseases depend on the ... Such complex research is no longer confined to a ... with varied backgrounds and expertise. That growing awareness ...
... along Massachusetts Bay,s busy shipping lanes this spring, thanks ... recognize whales, distinctive calls and route the information to ... giving ships the chance to avoid deadly collisions. ... -- developed at the Cornell Lab of Ornithology and ...
Cached Biology News:Cause and affect: Emotions can be unconsciously and subliminally evoked, study shows 2Cause and affect: Emotions can be unconsciously and subliminally evoked, study shows 3Brown opens institute for molecular and nanoscale innovation 2Warning buoys for right whales installed along Massachusetts Bay 2
... (OSM) is a pleiotropic cytokine produced by ... cells. OSM inhibits the growth of some ... smooth muscle and Kaposis sarcoma cell proliferation, ... density lipoprotein receptor expression on hepatoma cells. ...
... trinor Prostaglandin F2α isopropyl ester (15(R)-17-phenyl ... latanoprost-related isomer containing both a double ... (β) hydroxyl group at C-15. Similar ... ester is a potential impurity in ...
ACS Reagent Grade C 19 H 14 O 5 S Formula Weight: 354.38 PRODUCT SPECIFICATIONS Form: Rust/red crystalline powder Clarity of Solution: Passes test Visual Transition Interval: pH 6.8 - Yellow pH 8.2...
... Mouse Anti Nop1p/Fibrillarin (monoclonal) ... nucleolar protein of bakers yeast, Saccharomyces ... is essential for yeast viability and ... human homologue of Nop1p is fibrillarin ...
Biology Products: